Search

everythinglearnresearchcommunity

for

Search:↓

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

TLR4 is important in aging-related diseases and could be a new treatment target.

Using a special laser and skin medication together successfully cleared a skin condition in a pregnant woman.

Pustules in toxic erythema are linked to hair follicles or sweat ducts.

A man got a rare rash from the drug topiramate, which went away after he stopped taking it.

Severe digestive issues in DRESS need early endoscopy for better treatment.

Inflammation and Demodex mites might contribute to hair loss, and targeting them could help treat it.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

Lymphocytic mural folliculitis in cats might be an early sign of pancreatic cancer.

A woman had 13 non-cancerous cysts on her scalp successfully removed in one surgery.

Most HIV patients in the study showed skin and mucous membrane issues, with oral thrush being the most common.

ALDOA levels drop in hair cells during hair loss.

A girl with symptoms like an autoimmune disorder actually had HIV and a fungal infection, which was hard to diagnose and treat, leading to her death.

The document says that hookworms are treated with mebendazole and stress-related hair loss usually gets better in 6 months, while other hair loss types have specific treatments.

Radiotherapy effectively treated a large scalp tumor in an elderly woman, avoiding surgery.

PRP shows promise in musculoskeletal rehabilitation but needs standardized reporting for better outcomes.

PGD2 stops hair growth and is higher in bald men with AGA.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Skin fat helps with body temperature control and has other active roles in health.

Hormones, especially androgens, play a key role in acne, which can be a symptom of systemic diseases like PCOS and may require targeted treatment.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Prostaglandin E2 affects human platelet activity in complex ways that could lead to personalized heart disease treatments.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

Hair loss involves immune responses, inflammation, and disrupted signaling pathways.

Some acne medications have side effects; doctors should educate patients and may not need to do frequent lab tests for all.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

Most skin rashes in rheumatoid arthritis patients were not caused by their medication, and careful evaluation allowed most to keep taking their beneficial treatment.